Recent global studies have uncovered alarming findings about long-term health complications linked to COVID-19, indicating that neurological and respiratory disorders may persist for up to three years post-infection.
French Study: Increased Mortality and Hospitalization Risks
A French study, published in Infectious Diseases, analyzed data from 64,000 residents over 30 months. Key findings include:
ЁЯФ╣ Hospitalized COVID-19 patients faced a high mortality rate of 5,218 per 100,000 people.
ЁЯФ╣ Increased risk of neurological, psychiatric, cardiovascular, and respiratory complications.
ЁЯФ╣ Women were more susceptible to psychiatric hospitalizations, while individuals over 70 faced higher risks for organ-specific disorders.
ЁЯФ╣ Elevated risks for chronic kidney failure and diabetes persisted throughout the study period.
U.S. Study: Long COVID Effects Lasting Three Years
A separate U.S. study, conducted by researchers from Rush, Yale, and Washington universities, tracked 3,663 participants over three years and was published in The Lancet Regional Health. The study found:
тЬЕ Long COVID patients reported significantly worse physical and mental health outcomes.
тЬЕ Symptoms persisted in many cases, even after extended recovery periods.
тЬЕ Vaccination was linked to improved health outcomes, reducing long COVID severity.
Implications and Future Outlook
These findings highlight the prolonged impact of COVID-19 on global health, emphasizing the need for continued research, medical support for long COVID patients, and vaccination advocacy. Scientists stress the importance of early intervention and monitoring to manage these long-term complications effectively.
